TARO PHARMACEUTICAL INDS LTD (TARO)
Institutional ownership reported to the SEC as of Q3 2025, across 28 quarters.
1
Reporting holders
$3.3K
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| MassMutual Private Wealth & Trust, FSB | $3.3K | 76 | 0.00% | 6q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q3 2025 | 1 | $3.3K | 76 | 0 | 0 | 0 | 0.0% |
| Q2 2025 | 1 | $3.3K | 76 | 0 | 0 | 0 | 0.0% |
| Q1 2025 | 1 | $3.3K | 76 | 0 | 0 | 0 | 0.0% |
| Q4 2024 | 1 | $3.3K | 76 | 0 | 0 | 0 | 0.0% |
| Q3 2024 | 1 | $3.3K | 76 | 0 | 0 | 0 | 0.0% |
| Q2 2024 | 11 | $689.0K | 16,040 | 6 | 2 | 1 | 0.0% |
| Q1 2024 | 81 | $149.7M | 3,517,177 | 18 | 26 | 19 | 0.4% |
| Q4 2023 | 74 | $150.2M | 3,595,440 | 8 | 33 | 19 | 0.0% |
| Q3 2023 | 68 | $134.7M | 3,570,887 | 16 | 19 | 16 | 0.0% |
| Q2 2023 | 61 | $129.4M | 3,320,551 | 21 | 20 | 11 | 0.6% |
| Q1 2023 | 52 | $63.1M | 2,594,649 | 6 | 17 | 11 | 0.0% |
| Q4 2022 | 46 | $58.0M | 1,998,732 | 7 | 14 | 13 | 0.0% |
| Q3 2022 | 65 | $130.1M | 4,342,474 | 6 | 17 | 24 | 0.0% |
| Q2 2022 | 69 | $156.2M | 4,317,753 | 10 | 22 | 21 | 0.0% |
| Q1 2022 | 63 | $196.7M | 4,544,849 | 6 | 20 | 26 | 0.0% |
| Q4 2021 | 67 | $231.3M | 4,617,151 | 3 | 17 | 29 | 0.0% |
| Q3 2021 | 69 | $293.5M | 4,612,590 | 4 | 23 | 18 | 0.0% |
| Q2 2021 | 75 | $343.5M | 4,770,847 | 5 | 19 | 31 | 0.0% |
| Q1 2021 | 80 | $359.1M | 4,838,802 | 9 | 22 | 24 | 0.5% |
| Q4 2020 | 83 | $369.2M | 5,033,074 | 13 | 25 | 23 | 0.0% |
| Q3 2020 | 77 | $262.4M | 4,785,461 | 5 | 27 | 24 | 0.2% |
| Q2 2020 | 82 | $319.9M | 4,798,286 | 4 | 26 | 34 | 0.4% |
| Q1 2020 | 88 | $293.2M | 4,774,293 | 11 | 25 | 28 | 0.3% |
| Q4 2019 | 93 | $385.5M | 4,406,484 | 9 | 29 | 30 | 0.0% |
| Q3 2019 | 101 | $320.6M | 4,247,808 | 12 | 36 | 26 | 0.0% |
| Q2 2019 | 105 | $354.0M | 4,152,205 | 19 | 38 | 28 | 0.0% |
| Q1 2019 | 104 | $444.9M | 4,114,374 | 21 | 26 | 35 | 0.1% |
| Q4 2018 | 94 | $353.3M | 4,203,560 | 3 | 1 | 5 | 0.0% |